Form 4 for OPRX OptimizeRx Corp
Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-19 · accession 0001628280-25-058413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-22 | 2025-12-19 | OPRX | Stelmakh Edward | Chief Fin, Strat Off | S - Sale+OE | $13.51 | -1,388 | 126.8K | -1% | -$18.8K |
| D | 2025-12-22 | 2025-12-19 | OPRX | Stelmakh Edward | Chief Fin, Strat Off | M - OptEx | $0.00 | +5,237 | 128.2K | +4% | $0 |
| D | 2025-12-22 | 2025-12-19 | OPRX | Stelmakh Edward | Chief Fin, Strat Off | M - OptEx | $0.00 | -5,237 | 5,237 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | S | D | 1,388 | $13.51 | 126,830 | D | — | — | (F2) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock | 2025-12-19 | M | A | 5,237 | $0.00 | 128,218 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2025-12-19 | M | D | 5,237 | $0.00 | 5,237 | D | — · — to 2026-12-19 | 5,237 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date. |